Skip to content

Clinical trials

Phase 1/2 Leiomyosarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 1/2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20151
20171
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Terminated3
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Fred Hutchinson Cancer Center1
Memorial Sloan Kettering Cancer Center1
OncoResponse, Inc.1
STORM Therapeutics LTD1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma9
Liposarcoma7
Sarcoma6
Neurofibrosarcoma5
Histiocytoma, Malignant Fibrous4
Sarcoma, Synovial4
Dermatofibrosarcoma3
Osteosarcoma3
Chondrosarcoma2
Fibrosarcoma2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.